Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
– Sell
-245,648
Closed -$22.2M – 107
2014
Q2
$22.2M Sell
245,648
-13,487
-5% -$1.01M 0.47% 59
2014
Q1
$19.1M Sell
259,135
-14,560
-5% -$1.02M 0.41% 66
2013
Q4
$18.6M Sell
273,695
-13,245
-5% -$862K 0.36% 73
2013
Q3
$17.5M Sell
286,940
-44,512
-13% -$2.72M 0.3% 87
2013
Q2
$18.5M Buy
+331,452
New +$19.2M 0.31% 82

Other funds holding COV

CS McKee's COV Position: Q3 2014 in Review

CS McKee sold out of Covidien (COV) in Q3 2014, closing a stake of 245,648 shares — an estimated $22.2M sold.

CS McKee first reported a position in COV in Q2 2013 and held it in 5 quarters. The position peaked at $22.2M in Q2 2014. 720 funds tracked by Wall St. Rank hold COV as of Q3 2014.

  • CS McKee reported no remaining Covidien position as of Q3 2014 after selling out during the quarter.
  • CS McKee sold 245,648 Covidien shares in Q3 2014, an estimated $22.2M.
  • CS McKee first reported a position in Covidien in Q2 2013 and held it in 5 quarters.
  • CS McKee's Covidien position peaked at $22.2M in Q2 2014.
  • 720 funds tracked by Wall St. Rank held Covidien as of Q3 2014.

Based on CS McKee's 13F filing for Q3 2014, filed 14 Nov 2014.